Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis
Public ClinicalTrials.gov record NCT00385736. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind Placebo-controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to assess the efficacy and safety of adalimumab for the induction of clinical remission in subjects with moderately to severely active ulcerative colitis.
Study identification
- NCT ID
- NCT00385736
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 576 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2006 (Type not available)
- Primary completion
- Apr 2009 (Actual)
- Completion
- Mar 2010 (Actual)
- Last update posted
- Apr 11, 2011
2006 – 2010
United States locations
- U.S. sites
- 29
- U.S. states
- 19
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Ref # / Investigator 2080 | Birmingham | Alabama | 35209 | — |
| Site Ref # / Investigator 6034 | Mobile | Alabama | 36617 | — |
| Site Ref # / Investigator 5100 | Fayetteville | Arkansas | 72703 | — |
| Site Ref # / Investigator 5390 | Orange | California | 92868 | — |
| Site Ref # / Investigator 5392 | San Diego | California | 92123 | — |
| Site Ref # / Investigator 2245 | Bridgeport | Connecticut | 06606 | — |
| Site Ref # / Investigator 2240 | Gainesville | Florida | 32610 | — |
| Site Ref # / Investigator 2230 | South Miami | Florida | 33143 | — |
| Site Ref # / Investigator 5393 | Atlanta | Georgia | 30308 | — |
| Site Ref # / Investigator 2231 | Atlanta | Georgia | 30342 | — |
| Site Ref # / Investigator 2498 | Chicago | Illinois | 60637 | — |
| Site Ref # / Investigator 2078 | Chevy Chase | Maryland | 20815 | — |
| Site Ref # / Investigator 2238 | Silver Springs | Maryland | 20901 | — |
| Site Ref # / Investigator 1971 | Boston | Massachusetts | 02114 | — |
| Site Ref # / Investigator 2246 | Rochester | Minnesota | 55905 | — |
| Site Ref # / Investigator 2243 | Kansas City | Missouri | 64131 | — |
| Site Ref # / Investigator 2247 | Mexico | Missouri | 65265 | — |
| Site Ref # / Investigator 2233 | Lincoln | Nebraska | 68503 | — |
| Site Ref # / Investigator 2236 | Cedar Knolls | New Jersey | 07927 | — |
| Site Ref # / Investigator 2072 | New York | New York | 10028 | — |
| Site Ref # / Investigator 2241 | Charlotte | North Carolina | 28211 | — |
| Site Ref # / Investigator 2232 | Raleigh | North Carolina | 27612 | — |
| Site Ref # / Investigator 11801 | Wilmington | North Carolina | 28403 | — |
| Site Ref # / Investigator 2074 | Cincinnati | Ohio | 45219 | — |
| Site Ref # / Investigator 2126 | Cleveland | Ohio | 44106-5066 | — |
| Site Ref # / Investigator 6090 | Germantown | Tennessee | 38138 | — |
| Site Ref # / Investigator 2076 | Nashville | Tennessee | 37203 | — |
| Site Ref # / Investigator 2229 | Bellevue | Washington | 98004 | — |
| Site Ref # / Investigator 2077 | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00385736, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 11, 2011 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00385736 live on ClinicalTrials.gov.